Search concepts
|
Selected Filters
|
- 350 - 400 out of 1,360 results
Search results
-
Convergent AI for Precise Breast Cancer Risk Assessment
Wong, S. T., Chang, J. C. & Ensor, Jr., J. E.
6/1/20 → 5/31/25
Project: Federal Funding Agencies
-
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
6/1/20 → 5/31/22
Project: Federal Funding Agencies
-
LONGITUDINAL EARLY ONSET ALZHEIMER¿S DISEASE (LEADS) supplement
6/1/20 → 5/31/23
Project: Federal Funding Agencies
-
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Heyne, K., Singh, M. & Zhang, J.
5/27/20 → …
Project: Clinical Trial
-
A Phase III, Multicenter, Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care in the Treatment of Bronchiolitis Obliterans Syndrome in Patients post Single or Double Lung Transplantation (BT-L-CsA-303-FU (BOSTON-3))
Huang, H. J., Goodarzi, A., Yau, S. W. & Youssef, J. G.
5/27/20 → …
Project: Clinical Trial
-
Prospective Sudden Cardiac Death Risk Stratification Using Cardiac MRI and Echocardiography Machine Learning in Mitral Valve Prolapse.
5/26/20 → 4/30/25
Project: Federal Funding Agencies
-
SH-AltaValve
Reardon, M. J., Chang, S., Faza, N., Goel, S., Kleiman, N., Lawrie, G. M. & Little, S. H.
5/19/20 → …
Project: Clinical Trial
-
A Phase 1a/b Dose-Escalation Study Followed by Expansion Cohorts of NGM120, a GFRAL Antagonist Monoclonal Antibody Blocking GDF15 Signaling, in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy
Singh, M., Abdelrahim, M., Beinart, G. & Heyne, K.
5/18/20 → …
Project: Clinical Trial
-
-
Evaluation of immune responses to CD44-targeted nanovectors for designing a novel anti-tuberculosis host-directed therapy
Godin, B., Jagannath, C. & Leonard, F.
5/1/20 → 10/31/22
Project: Federal Funding Agencies
-
Registry for Neurological Endpoint Assessments among patients with Ischemic and Hemorrhagic Stroke (REINAH)
Vahidy, F. S., Britz, G. W., Horner, P. J. & Misra, V.
4/28/20 → …
Project: Clinical Trial
-
A PILOT RANDOMIZED CONTROLLED TRIAL OF DE NOVO BELATACEPT-BASED IMMUNOSUPPRESSION IN LUNG TRANSPLANTATION
Huang, H. J., Goodarzi, A. & Yau, S. W.
4/23/20 → …
Project: Clinical Trial
-
-
-
Biodegradability and Biocompatiblity of a Shape Memory Polymer Wrap to Improve Saphenous Vein Graft Patency in Peripheral and Coronary Artery Bypass Grafting Surgeries
Peden, E. K., Cooke, J. P. & Karmonik, C.
4/15/20 → 10/31/21
Project: Federal Funding Agencies
-
A new conditional TDP¿NLS knock-in mouse model generated using CRISPR/Cas9 technology to study the linkage of TDP-43 pathology to motor and cognitive defects in ALS, FTD and ADRD
Hegde, M., Mitra, J. & Wang, H.
4/15/20 → 2/28/23
Project: Federal Funding Agencies
-
Defining the altered FUS-PARP-1-DNA Ligase III axis and its implications to nuclear and mitochondrial genome damage response in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
Hegde, M., Hamilton, D. J., Horner, P. J., Mitra, J. & Wang, H.
4/15/20 → 3/31/25
Project: Federal Funding Agencies
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C., Bernicker, E. H., Darcourt, J., Heyne, K., Niravath, P. A. & Singh, M.
4/9/20 → …
Project: Clinical Trial
-
Intraoperative Analytics and Enhanced Patient Outcomes
4/5/20 → 5/4/21
Project: Federal Funding Agencies
-
Novel carbon nanozyme mechanisms for traumatic brain injury therapy
4/1/20 → 3/31/25
Project: Federal Funding Agencies
-
U.S. Study to Protect Brain Health through Lifestyle Intervention to Reduce Risk:Neuroimaging Ancillary Study
4/1/20 → 6/30/23
Project: Federal Funding Agencies
-
Myotonic Dystrophy Compilation of Clinical Findings
Greene, E. P., Appel, S. H., Ashizawa, T., Mathuria, N., Shroff, S. & Thonhoff, J. R.
4/1/20 → …
Project: Clinical Trial
-
LEAP-012 - MERCK (7902-012, Site No. 0784) Safety and Efficacy of Lenvatinib (E7080 / MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable / Non-metastatic Hepatocellular Carcinoma (MK-7902-012 / E7080-G000-318 / LEAP-012)
Kodali, S., Abdelrahim, M., Ghobrial, R. M., Gibbs, J. M., Heyne, K., Saharia, A., Shetty, A. & Victor, III, D. W.
3/27/20 → …
Project: Clinical Trial
-
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation
3/26/20 → 3/25/45
Project: Non Profit
-
AOCT - COVID-19 Plasma Donation
Castillo, B., Chen, J. & Leveque, C.
3/26/20 → …
Project: Clinical Trial
-
Receptive Music Approach to Improve Agitation in Hospitalized Dementia Patients
3/23/20 → 6/30/21
Project: Non Profit
-
Building Resilience in Caregivers of Trauma Survivors
3/15/20 → 9/29/22
Project: Federal Funding Agencies
-
-
Exercise Intervention for Strong and Fit Pediatric Fontan Patients (StrongFitFontan)
3/10/20 → 2/28/25
Project: Federal Funding Agencies
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K. & Niravath, P. A.
3/6/20 → 3/5/45
Project: Non Profit
-
INTEGRATION OF IMMUNOTHERAPY INTO ADJUVANT THERAPY FOR RESECTED NSCLC: ALCHEMIST CHEMO-IO (ACCIO)
3/6/20 → 3/5/45
Project: Non Profit
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
Imaging the mechanical microenvironment in cancers using ultrasound
3/1/20 → 2/28/23
Project: Federal Funding Agencies
-
A DNAzyme that targets the CAG repeat RNA in polyglutamine diseases
3/1/20 → 2/28/21
Project: Non Profit
-
FDP Sub in - MESENCHYMAL STEM CELLS FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME
Zainab, A., Hsu, S. H., Masud, F. N. & Reardon, M. J.
3/1/20 → 2/28/22
Project: Federal Funding Agencies
-
Molecular mechanism of streptococcal adaptation to host nutritional defenses
Kumaraswami, M. & Olsen, R. J.
2/25/20 → 1/31/25
Project: Federal Funding Agencies
-
Ocrelizumab for Psychosis by Autoimmunity (OPA)
Masdeu, J. C., Faridar, A., Nakawah, M. O., Pascual, B., Toledo, J. B. & Weinstein, B.
2/20/20 → …
Project: Clinical Trial
-
Systematic identification of astrocyte-tumor crosstalk regulating brain metastatic tumors
Wong, S. T., Zhao, H., Rostomily, R. C. & Sheng, J.
2/15/20 → 1/31/25
Project: Federal Funding Agencies
-
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells
2/15/20 → 1/31/25
Project: Federal Funding Agencies
-
Mild Hypothermia and Acute Kidney Injury AKI in Liver Transplantation MHALT Trial
Ghobrial, R. M., Lindberg, S., Mobley, C. M., Saharia, A. & Victor, III, D. W.
2/10/20 → …
Project: Clinical Trial
-
Assessing CSF flow in glymphatics
Britz, G. W., Golanov, E. V., Karmonik, C. & Regnier-Golanov, A.
2/5/20 → …
Project: Clinical Trial
-
-
Role of integrin VLA-6 in suppression of bone formation in myeloma
2/1/20 → 1/31/23
Project: Federal Funding Agencies
-
Regulation of Glycogen Synthase 3 pathway by Polycystin-1 in Cardiomyocytes
2/1/20 → 1/31/21
Project: Federal Funding Agencies
-
Ultra High-Field MR Spectroscopy of Non-alcoholic fatty liver disease
Victor, III, D. W., Ghobrial, R. M., Graviss, E. A., Gupta, N. & Karmonik, C.
1/30/20 → …
Project: Clinical Trial
-
REDUCE PAS
Lin, C. H., Chiu, D., Gadhia, R. R., Kleiman, N., Misra, V. & Volpi, J. J.
1/28/20 → …
Project: Clinical Trial